Pharmacology Unit 4 Flashcards
selective toxicity-define
- feature of antibiotic therapy as effects of antimicrobial agents should be exerted on microbe and not host.
- targets biochemical differences between pathogen target and host–>exploitation of these differences
selective toxicity-examples
-inhibition of metabolic pathway in bacteria but not humans–folate metabolism (metabolize intracellularly, mammals take up from environment)
-pathways that exist in both but are different in enzyme structure–protein synthesis (bacterial ribosomes that are 30 and 50S vs. 40 and 60S.
nucleic acid synthesis (DNA gyrase vs topoisomerase)
- macromolecular structure doesn’t exist in humans (cell wall synthesis, peptidoglycan component)
- macromolecular structure differs between humans and microbes (fungal cell membrane-ergosterol)
narrow vs. extended vs. broad antibacterial spectrum: basic definitions of the 3
narrow spectrum–most effective on susceptible organism, less disturbance of host flora. GRAM POSITIVE OR NEGATIVE
broad spectrum–sacrifice efficacy for greater scope of activity for initial empiric coverage, more likely to cause superinfections. GRAM POSITIVE AND NEGATIVE
extended spectrum–effective against gram positive and gram negative
narrow antibacterial examples (gram + or -)
aminoglycosides penicillinase-resistance penicillins clindamycin vancomycin metronidazole penicillin g, v
extended antibacterial examples (gram + and -)
extended-spectrum penicillins
cephalosporins
fluoroquinolones (cip, levo)
carbapenems
broad antibacterial examples (gram + and - and atypical)
macrolides chloramphenicol fluroquinolones (moxi, gemi) sulfonamides tetracyclines trimethoprim
resistance: chromosomal vs. plasmid mediated
mutational (chromosomal) resistance: effect varies, multiple generations must happen to see appreciable resistance. proper dosing prevents survival of slightly resistant strains
plasmid mediated resistance: extrachrosomal pieces of circular DNA, carrying genetic information that can confer resistance. source of multiple drug resistances that can emerge in 1 course of treatment
resistance: mechanisms
natural
natural (intrinsic) resistance: microbes lack susceptible target for drug action
-(fungal cell walls don’t have peptidoglycan and mycoplasma have no walls).
pseudomonas auerginosa is intrinsically resistant to many antibiotics (can’t cross the membrane)
resistance: mechanisms
escape
microbes are sensitive and antibiotic reaches target but organism “escapes” consequences due to availability of purines, thymidine, serine, methionine released from purulent infections (sulfonamide resistance)
failure to lyse due to lack of osmotic pressure difference (penicillin resistance)
importance drainage surgical procedures
resistance: mechanisms
acquired
selective pressure (antibiotic administration) produces generations of organisms with biochemical traits that minimize drug action
mutational
plasmid
resistance: implications for therapy
can be minimized by only using antibiotic when needed, select based on susceptibility tests, use adequate concentration and duration to prevent emergence of first and second step mutants.
classifications of antimicrobial mechanisms of action
altered targets enzymatic destruction alternative resistant metabolic pathway decreased entry increased efflux
bactericidal agents vs bacteriostatic agents definitions
bactericidal: organisms are killed
bacteriostatic: organisms are prevented from growing
bactericidal mechanisms
inhibition of cell wall synthesis
disruption of cell membrane function
interference with dan function/synthesis
bacteriostatic mechanisms
inhibition of protein synthesis (exception is aminoglycosides, -cidal)
inhibition of intermediary metabolic pathways
advantages of bactericidal agents
- preferred in severe infections (assuming sensitive organism, drug distribution, drug safety)
- act more quickly, action is often irreversible (sustained effect after drug is eliminated from blood)
- compensate for patients with impaired host defense (diabetes, etc.)
- required for treatment of infections in locations not accessible to host immune system responses (endocarditic vegetation, CSF)
importance of pharmacokinetic and host factors in selection of antimicrobial therapy
consider pharmacodynamics (antimicrobial activity against specific organism), pharmacokinetic properties (absorption from route of administration), distribution (to site of infection), elimination (hepatic or renal) as related to duration of antimicrobial activity
absorption (oral vs. parenteral vs. topical)
oral: advantage of ease, acceptance, lower cost. can cause GI upset/diarrhea, if NPO.
IV: needed for some drugs/patients has advantage of most rapid/predictable plasma levels (treating life-threatening infections). disadvantage needed with IV are greater training, expense, specific antiseptic conditions
switch to oral whenever and whenever possible
infections can be managed with local application of antibiotic (skin or mucus membranes)
distribution (CNS penetration, fetal exposure, selective accumulation-beneficial vs. harmful)
once antibiotic has been absorbed into systemic circulation must be distributed
CNS: most antibiotics distribute to tissue outside CNS, vary based in ability to cross BBB.
fetus: adverse effects may occur in the fetus that cross placenta. can be given orally, and have ability to cross gastric and placenta
selective-accumulation: certain antibiotics can result in harmful/beneficial response
beneficial: clindamycin into bone, treat osteomyelitis. concentrations of macrolides into pulmonary cells (upper respiratory infections). tetracyclines into gingival crevicular fluid. rapid excretion of nitrofurantoin
selective-increase toxicity: include amino glycoside binding to cells of inner ear, brush border. results increased ototoxicity, nephrotoxicity, tetracyclines-bind to developing bone and teeth to result in abnormal bone growth
elimination
renal: alerts to possibility of renal dosing if necessary in patients with kidney dysfunction. process where dose and frequency are adjusted based on renal function. measure SCr and CrCl
hepatic: possibility of drug-drug interactions or hepatotoxic antibiotics. no lab value to give estimate of liver function
drug classes eliminated by renal excretion
require dosage adjustment if impaired penicillins cephalosporins vancomycin aminoglycosides fluoroquinolones
drug classes eliminated by non renal mechanisms-use your mnemonic!!!
DQ CRIME
Doxycycline: non-regally eliminated tetracycline
(Q)uinolones: ciprofloxacin is really eliminated, but is non-substrate inhibitor of P450 (caffeine-theophylline)
Clindamycin: non-regally eliminated
Rifampin: inducer of P450, potential hepatotoxicity
Isoniazid: genetic polymorphism of n-acetyl transferase metabolism, potential hepatotoxicity
Metronidazole: drug-drug interaction with alcohol due to inhibition of aldehyde metabolism (Antabuse reaction)
Erythromycin-like: drug-drug interactions due to inhibition of P450 (Clar-Ery, not Azi)
Sulfonamides: n-acetylated to a more lipid-soluble metabolite-concern for renal crystalluria
strep pneumoniae
pneumonia, otitis media, sinusitis
cocci-gram +
strep pyogenes
pharyngitis
cocci-gram +
viridans streptococci
endocarditis
cocci-gram +
staph aureus
(MSSA, MRSA)
cutaneous infection, pneumonia, bacteremia, device associated infections
cocci-gram +
enterococcus faecium-faecalis
bacterimia, intraabdominal infections, UTI
cocci-gram +
neisseria gonorrheae
gonorrhea
cocci-gram -
neisseria meningitidis
meningitis
cocci-gram -
ecoli
utis, intra-abdominal infections, lower respiratory infections, bacteremias, traveler’s diarrhea
rods- gram -
pseudomonas aeruginosa
noncosomial infections at any site (UTI, pneumonia)
rods- gram -
clostridium difficile
pseudomembranous colitis
anerobes-gram + rod
clostridium perfringens-botulinim-tetani
anerobes-gram + rod
bacteriodes fragilis
intraabdominal and brain abcess
anerobes-gram - rod
clamydia
trachoma, community acquired pneumonia, urethitis
atypical
mycoplsma pneumoniae
community acquired pneumonia
atypical
side effects: direct toxicity
antibiotic effect on microbes affects host cellular processes (lack of selective toxicity)
- varies with drugs and concentrations
- can be mild/life threatening
- usually involves GI tract, liver, kidney, nervous system, blood and blood forming system
side effects: indirect toxicity
allergic reactions, hypersensitivity salt effects (salt administered with antibiotic not antibiotic) drug-drug interactions, may alter CYP450 drug metabolizing enzymes
side effects: superinfections
disturbances in ecological balance of microbial community
allows for overgrowth of normally suppressed pathogenic organism
pseudomembranous colitis due to clostridium difficile overgrowth
more commonly associated with broad spectrum antibiotics
increased if 50, pulmonary disease, prolonged duration
cell wall synthesis inhibitors: penicillins-prototype
penicilin G